640.05澳幣4.75(0.75%)
2023/09/26更新
績效 / 1月2.93%
3月6.73%
1年0.04%
晨星評等-
- 1.現金1.14%
- 2.股票11.06%
- 3.債券0.13%
- 4.其他87.67%
- 1.美國87.78%
- 2.加拿大5.12%
- 3.歐洲不包含歐元區2.87%
- 4.英國1.89%
- 5.新興亞洲1.19%
- 1.argenx SE ADR6.60%
- 2.Vertex Pharmaceuticals Inc5.00%
- 3.Biogen Inc4.96%
- 4.Biomarin Pharmaceutical Inc4.04%
- 5.Amgen Inc3.67%
- 6.Alnylam Pharmaceuticals Inc3.19%
- 7.Xenon Pharmaceuticals Inc3.08%
- 8.Seagen Inc Ordinary Shares3.07%
- 9.Intra-Cellular Therapies Inc2.98%
- 10.Vaxcyte Inc Ordinary Shares2.76%
- 1.現金1.14%
- 2.股票11.06%
- 3.債券0.13%
- 4.其他87.67%
- 1.美國87.78%
- 2.加拿大5.12%
- 3.歐洲不包含歐元區2.87%
- 4.英國1.89%
- 5.新興亞洲1.19%
- 1.argenx SE ADR6.60%
- 2.Vertex Pharmaceuticals Inc5.00%
- 3.Biogen Inc4.96%
- 4.Biomarin Pharmaceutical Inc4.04%
- 5.Amgen Inc3.67%
- 6.Alnylam Pharmaceuticals Inc3.19%
- 7.Xenon Pharmaceuticals Inc3.08%
- 8.Seagen Inc Ordinary Shares3.07%
- 9.Intra-Cellular Therapies Inc2.98%
- 10.Vaxcyte Inc Ordinary Shares2.76%